A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by an independent data monitoring committee (IDMC) determined that Sanofi and Johnson & Johnson’s ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...

Febrile infants aged 22 to 60 days were less likely to be hospitalized or receive antibiotics after the AAP published updated ...

In another in the seemingly endless series of decisions parsing the interpretation of the statutory requirements for an affidavit of merit in ...

Referral to an infectious disease physician was the only modifiable strategy to reduce 28-day mortality among adults presenting to the ED with bacteremia.

Pregnant patients in their third trimester and postpartum women showed higher risk for IPD compared with nonpregnant patients.

While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults. The most common symptoms include cough, chills and fever.

During the 11-year study, there were 72 incident cases of Fusobacterium bacteremia. Basic demographic (age, gender, residency) and microbiologic data were available for all cases. Of the ten cases ...

Background: This study aimed to assess the distribution of bacteremia pathogens in elderly patients, examine the impact of gender on pathogen distribution, and evaluate the predictive value of routine ...

Risk factors include Staphylococcus aureus nasal colonization, longer duration of catheter use, previous bacteremia, older age, higher total intravenous iron dose, lower hemoglobin and serum ...